1. Home
  2. DVA vs NBIS Comparison

DVA vs NBIS Comparison

Compare DVA & NBIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • NBIS
  • Stock Information
  • Founded
  • DVA 1994
  • NBIS 2000
  • Country
  • DVA United States
  • NBIS Netherlands
  • Employees
  • DVA N/A
  • NBIS N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • NBIS
  • Sector
  • DVA Health Care
  • NBIS
  • Exchange
  • DVA Nasdaq
  • NBIS NYSE
  • Market Cap
  • DVA 10.8B
  • NBIS 10.6B
  • IPO Year
  • DVA 1995
  • NBIS 2011
  • Fundamental
  • Price
  • DVA $146.06
  • NBIS $51.20
  • Analyst Decision
  • DVA Hold
  • NBIS Strong Buy
  • Analyst Count
  • DVA 4
  • NBIS 4
  • Target Price
  • DVA $157.00
  • NBIS $62.50
  • AVG Volume (30 Days)
  • DVA 752.6K
  • NBIS 12.2M
  • Earning Date
  • DVA 08-05-2025
  • NBIS 08-04-2025
  • Dividend Yield
  • DVA N/A
  • NBIS N/A
  • EPS Growth
  • DVA 14.90
  • NBIS N/A
  • EPS
  • DVA 10.11
  • NBIS N/A
  • Revenue
  • DVA $12,968,524,000.00
  • NBIS $161,400,000.00
  • Revenue This Year
  • DVA $6.51
  • NBIS $38,351.91
  • Revenue Next Year
  • DVA $3.41
  • NBIS $134.64
  • P/E Ratio
  • DVA $14.44
  • NBIS N/A
  • Revenue Growth
  • DVA 5.11
  • NBIS N/A
  • 52 Week Low
  • DVA $131.76
  • NBIS $14.09
  • 52 Week High
  • DVA $179.60
  • NBIS $58.16
  • Technical
  • Relative Strength Index (RSI)
  • DVA 56.00
  • NBIS N/A
  • Support Level
  • DVA $138.65
  • NBIS N/A
  • Resistance Level
  • DVA $144.07
  • NBIS N/A
  • Average True Range (ATR)
  • DVA 3.16
  • NBIS 0.00
  • MACD
  • DVA -0.09
  • NBIS 0.00
  • Stochastic Oscillator
  • DVA 75.61
  • NBIS 0.00

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About NBIS NEBIUS GROUP N V

Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.

Share on Social Networks: